Schizophrenia is a relapsing disorder. The main goal of neuroleptic mainten
ance treatment is relapse prevention, which is empirically well proven. Ava
ilability of different kinds of treatment strategies including new antipsyc
hotic drugs with improved risk/benefit profile allow long-term treatment to
be individually tailored. Treatment guidelines developed mainly by the sci
entific medical societies can help the practitioner in making the right dec
isions.